tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALNY Stock Latest News

Alnylam’s ELEVATE Study: A Closer Look at AHP Treatment Advancements
Company AnnouncementsAlnylam’s ELEVATE Study: A Closer Look at AHP Treatment Advancements
9h ago
ALNY
Alnylam’s Phase 1 Study on ALN-4324: A Potential Game-Changer in Obesity Treatment?
PremiumCompany Announcements
Alnylam’s Phase 1 Study on ALN-4324: A Potential Game-Changer in Obesity Treatment?
9h ago
ALNY
Alnylam’s Phase 1 Study on ALN-BCAT: A Potential Game-Changer in Liver Cancer Treatment
PremiumCompany Announcements
Alnylam’s Phase 1 Study on ALN-BCAT: A Potential Game-Changer in Liver Cancer Treatment
9h ago
ALNY
Alnylam’s ALN-HTT02 Study: A Promising Step in Huntington’s Disease Treatment
PremiumCompany Announcements
Alnylam’s ALN-HTT02 Study: A Promising Step in Huntington’s Disease Treatment
9h ago
ALNY
Alnylam’s ConTTRibute Study: A Closer Look at ATTR Amyloidosis Treatment
PremiumCompany Announcements
Alnylam’s ConTTRibute Study: A Closer Look at ATTR Amyloidosis Treatment
9h ago
ALNY
Alnylam Pharmaceuticals Advances Phase 2 Trial for CAA Treatment
PremiumCompany AnnouncementsAlnylam Pharmaceuticals Advances Phase 2 Trial for CAA Treatment
9h ago
ALNY
Alnylam’s Patisiran Pregnancy Study: A Closer Look at Market Implications
Premium
Company Announcements
Alnylam’s Patisiran Pregnancy Study: A Closer Look at Market Implications
10h ago
ALNY
Buy Rating for Alnylam Pharma: Strong Amvuttra Performance and Promising Pipeline Drive Positive Outlook
Premium
Ratings
Buy Rating for Alnylam Pharma: Strong Amvuttra Performance and Promising Pipeline Drive Positive Outlook
15h ago
ALNY
Alnylam price target raised to $348 from $338 at JPMorgan
PremiumThe Fly
Alnylam price target raised to $348 from $338 at JPMorgan
15h ago
ALNY
Alnylam price target raised to $312 from $287 at Morgan Stanley
PremiumThe Fly
Alnylam price target raised to $312 from $287 at Morgan Stanley
2d ago
ALNY
BridgeBio price target raised to $56 from $53 at Leerink
PremiumThe Fly
BridgeBio price target raised to $56 from $53 at Leerink
3d ago
ALNY
BBIO
Alnylam price target raised to $359 from $336 at BofA
PremiumThe Fly
Alnylam price target raised to $359 from $336 at BofA
6d ago
ALNY
Alnylam price target raised to $404 from $364 at Citi
PremiumThe FlyAlnylam price target raised to $404 from $364 at Citi
6d ago
ALNY
Alnylam Pharma’s Promising Growth and Market Potential Justify Buy Rating
Premium
Ratings
Alnylam Pharma’s Promising Growth and Market Potential Justify Buy Rating
6d ago
ALNY
Alnylam price target raised to $384 from $328 at Jefferies
Premium
The Fly
Alnylam price target raised to $384 from $328 at Jefferies
10d ago
ALNY
Alnylam announces reimbursement of OXLUMO in Canada
PremiumThe Fly
Alnylam announces reimbursement of OXLUMO in Canada
14d ago
ALNY
Strong Sales Momentum and Growth Potential Drive Buy Rating for Alnylam Pharma’s Amvuttra
PremiumRatings
Strong Sales Momentum and Growth Potential Drive Buy Rating for Alnylam Pharma’s Amvuttra
17d ago
ALNY
Alnylam’s NeuroFeeL Study: A New Frontier in Amyloidosis Biomarker Research
PremiumCompany Announcements
Alnylam’s NeuroFeeL Study: A New Frontier in Amyloidosis Biomarker Research
19d ago
ALNY
Alnylam price target raised to $377 from $320 at Needham
PremiumThe Fly
Alnylam price target raised to $377 from $320 at Needham
21d ago
ALNY
Alnylam Pharma’s Promising Outlook: Analyst Joseph Stringer Raises Price Target Amid Optimism for Amvuttra Launch
PremiumRatingsAlnylam Pharma’s Promising Outlook: Analyst Joseph Stringer Raises Price Target Amid Optimism for Amvuttra Launch
21d ago
ALNY
Alnylam’s NeuroFeeL Study: A New Frontier in Biomarker Research
Premium
Company Announcements
Alnylam’s NeuroFeeL Study: A New Frontier in Biomarker Research
21d ago
ALNY
Alnylam price target raised to $360 from $300 at BMO Capital
Premium
The Fly
Alnylam price target raised to $360 from $300 at BMO Capital
23d ago
IQV
ALNY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >